NIH-funded research Career grant

Improving T cell therapy for better cancer treatment

Official title: Next-generation T cell therapy: SMARTER T cells for enhanced and durable anti-tumor immunity

Funded at Univ of North Carolina Chapel Hill · NIH-11176359 · Data updated 2026-11-12

This study is working on improving a type of cancer treatment that uses your own immune cells, called T cells, to help them better fight tumors and survive in tough environments, so patients can have more effective options for battling cancer.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startJune 1, 2023
Project endMay 31, 2027
Funding year2025
Award (this year)$159,840
NIH project number5K01EB034321-03
Project IDNIH-11176359 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients with solid tumors who may benefit from enhanced T cell therapies.

Less likely to help

Patients with non-solid tumors or those who do not respond to T cell therapies may not receive benefit from this research.

What this research studies

This research focuses on enhancing T cell therapy, specifically engineered CD8+ T cells, to improve their ability to infiltrate and survive within tumors. By addressing the challenges posed by the hostile tumor microenvironment, the study aims to develop T cells that can provide a more durable anti-tumor immune response. The approach combines expertise in T cell development, genomic analysis, and protein engineering to create a novel solution for current limitations in adoptive cell therapy. Patients may benefit from more effective cancer treatments that harness their own immune cells.

Why it matters

Potential benefit: If successful, this research could lead to more effective and long-lasting cancer treatments for patients.

How similar studies have gone: Other research has shown promise in enhancing T cell therapies, but this approach aims to address specific challenges that have not been fully resolved.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Chung, Hokyung Kay — Univ of North Carolina Chapel Hill
  • Study coordinator: Chung, Hokyung Kay

Related research

Other NIH-funded projects on the same topics.

  • A center for coordinating data related to heart and blood health.

    This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-9732880

  • Healthy work design and worker well-being

    A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11631666

  • Unified and fair multimodal learning for autoimmune diseases

    A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11625649

  • Structural factors linking minimum wage, COVID-19, and community violence

    A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11624218

  • Non-invasive tears biomarker for early Alzheimer's in LMICs

    A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

  • How HPV interacts with our cells' DNA damage system and its effect on cancer

    This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11622604

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.